10-4995770-A-G

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001393392.1(AKR1C2):​c.666T>C​(p.His222His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00262 in 1,596,910 control chromosomes in the GnomAD database, including 85 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.018 ( 47 hom., cov: 27)
Exomes 𝑓: 0.0011 ( 38 hom. )

Consequence

AKR1C2
NM_001393392.1 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts P:1B:3

Conservation

PhyloP100: -4.51

Publications

10 publications found
Variant links:
Genes affected
AKR1C2 (HGNC:385): (aldo-keto reductase family 1 member C2) This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. These enzymes catalyze the conversion of aldehydes and ketones to their corresponding alcohols using NADH and/or NADPH as cofactors. The enzymes display overlapping but distinct substrate specificity. This enzyme binds bile acid with high affinity, and shows minimal 3-alpha-hydroxysteroid dehydrogenase activity. This gene shares high sequence identity with three other gene members and is clustered with those three genes at chromosome 10p15-p14. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
AKR1C2 Gene-Disease associations (from GenCC):
  • 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency
    Inheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 10-4995770-A-G is Benign according to our data. Variant chr10-4995770-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 805966.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 47 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AKR1C2NM_001393392.1 linkc.666T>C p.His222His synonymous_variant Exon 6 of 9 ENST00000380753.9 NP_001380321.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AKR1C2ENST00000380753.9 linkc.666T>C p.His222His synonymous_variant Exon 6 of 9 1 NM_001393392.1 ENSP00000370129.4

Frequencies

GnomAD3 genomes
AF:
0.0176
AC:
2569
AN:
146338
Hom.:
44
Cov.:
27
show subpopulations
Gnomad AFR
AF:
0.0586
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00564
Gnomad ASJ
AF:
0.00349
Gnomad EAS
AF:
0.000802
Gnomad SAS
AF:
0.00113
Gnomad FIN
AF:
0.00109
Gnomad MID
AF:
0.00980
Gnomad NFE
AF:
0.00126
Gnomad OTH
AF:
0.0145
GnomAD2 exomes
AF:
0.000236
AC:
59
AN:
250002
AF XY:
0.000126
show subpopulations
Gnomad AFR exome
AF:
0.00224
Gnomad AMR exome
AF:
0.000262
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000545
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000793
Gnomad OTH exome
AF:
0.000328
GnomAD4 exome
AF:
0.00111
AC:
1606
AN:
1450458
Hom.:
38
Cov.:
32
AF XY:
0.00102
AC XY:
737
AN XY:
721284
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0269
AC:
867
AN:
32254
American (AMR)
AF:
0.00189
AC:
84
AN:
44442
Ashkenazi Jewish (ASJ)
AF:
0.00224
AC:
56
AN:
24952
East Asian (EAS)
AF:
0.000252
AC:
10
AN:
39646
South Asian (SAS)
AF:
0.000692
AC:
59
AN:
85312
European-Finnish (FIN)
AF:
0.000703
AC:
37
AN:
52618
Middle Eastern (MID)
AF:
0.00158
AC:
9
AN:
5702
European-Non Finnish (NFE)
AF:
0.000283
AC:
313
AN:
1105928
Other (OTH)
AF:
0.00287
AC:
171
AN:
59604
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.321
Heterozygous variant carriers
0
87
174
262
349
436
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0176
AC:
2584
AN:
146452
Hom.:
47
Cov.:
27
AF XY:
0.0168
AC XY:
1198
AN XY:
71504
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0588
AC:
2355
AN:
40062
American (AMR)
AF:
0.00564
AC:
83
AN:
14724
Ashkenazi Jewish (ASJ)
AF:
0.00349
AC:
11
AN:
3148
East Asian (EAS)
AF:
0.000804
AC:
4
AN:
4974
South Asian (SAS)
AF:
0.00113
AC:
5
AN:
4428
European-Finnish (FIN)
AF:
0.00109
AC:
11
AN:
10106
Middle Eastern (MID)
AF:
0.0106
AC:
3
AN:
284
European-Non Finnish (NFE)
AF:
0.00126
AC:
83
AN:
65804
Other (OTH)
AF:
0.0144
AC:
29
AN:
2012
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.352
Heterozygous variant carriers
0
120
240
359
479
599
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0125
Hom.:
4
EpiCase
AF:
0.000164
EpiControl
AF:
0.0000594

ClinVar

Significance: Benign/Likely benign
Submissions summary: Pathogenic:1Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

CIC-rearranged sarcoma Pathogenic:1
Children's Cancer Therapy Development Institute
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

not specified Benign:1
May 04, 2022
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

46,XY disorder of sex development due to testicular 17,20-desmolase deficiency Benign:1
Apr 20, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

AKR1C2-related disorder Benign:1
Apr 05, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
0.11
DANN
Benign
0.45
PhyloP100
-4.5
Mutation Taster
=100/0
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13222; hg19: chr10-5037962; COSMIC: COSV66332725; COSMIC: COSV66332725; API